Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Ivan Lyagoskin"'
Autor:
Ekaterina Zubareva, Maksim Degterev, Alexander Kazarov, Maria Zhiliaeva, Ksenia Ulyanova, Vladimir Simonov, Ivan Lyagoskin, Maksim Smolov, Madina Iskakova, Anna Azarova, Rahim Shukurov
Publikováno v:
Pharmaceuticals, Vol 14, Iss 11, p 1180 (2021)
The disfunction or deficiency of the C1 esterase inhibitor (C1INH) is associated with hereditary or acquired angioedema (HAE/AAE), a rare life-threatening condition characterized by swelling in the skin, respiratory and gastrointestinal tracts. The c
Externí odkaz:
https://doaj.org/article/b7adc867c7b4424d92943805cd97fb6c
Autor:
Valentina Gusarova, Maxim Degterev, Ivan Lyagoskin, Vladimir Simonov, Maxim Smolov, Sergey Taran, Rahim Shukurov
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 220
A recombinant humanized monoclonal antibody (mAb) Eculizumab, C5-complement cascade inhibitor, is an important treatment of complement-based diseases recommended by international guidelines. Elizaria® Drug Product (DP), developed by IBC Generium, Ru
Autor:
E. V. Zubareva, Ivan Lyagoskin, Maria Zhiliaeva, Rahim Shukurov, Maksim Degterev, Madina Iskakova, Ksenia Ulyanova, Maksim Smolov, Vladimir Simonov, Alexander Kazarov, Anna Azarova
Publikováno v:
Pharmaceuticals
Volume 14
Issue 11
Pharmaceuticals, Vol 14, Iss 1180, p 1180 (2021)
Volume 14
Issue 11
Pharmaceuticals, Vol 14, Iss 1180, p 1180 (2021)
The disfunction or deficiency of the C1 esterase inhibitor (C1INH) is associated with hereditary or acquired angioedema (HAE/AAE), a rare life-threatening condition characterized by swelling in the skin, respiratory and gastrointestinal tracts. The c